stocksfeed.ai
← Back to news feed

MRNA overview

MRNA
Moderna, Inc.
196.79
USD
-21.45 (-9.83%)since Nov 16, 2026

News about MRNA

2 stories shown

MRNAMRKproduct launch

Major pharmaceutical companies are investing billions in vaccines, including promising cancer and shingles vaccines, despite political hurdles.

MarketWatch
View original
MRNAother

MSCI announced its November 2026 review, adding Moderna to the World Index alongside changes to its U.S. Prime Market 750 index.

Seeking Alpha
View original